Advanced company searchLink opens in new window

4D PHARMA PLC

Company number 08840579

Charge code 0884 0579 0003

Created
29 July 2021
Delivered
10 August 2021
Status
Outstanding
Transaction Filed
Registration of a charge (MR01)

Assets ceased/released

Part of the property or undertaking has been released and no longer forms part of the charge

Persons entitled

  • Oxford Finance Luxembourg Sàrl (Acting in Respect of Its Compartment 4) as Collateral Agent

Brief description

1. patents.. Family: 17; priority date: 4 march 2016; filing date: 6 march 2017; territory: europe; application no.: 17709911.6; publication no.: 3313423; patent no.: 3313423; status: granted, validated in the united kingdom; current expiry: 6 march 2037; summary of coverage: blautix in the treatment of visceral hypersensitivity; proprietor: 4D pharma PLC.. For further details of the patents subject to this charge please see part 1 of schedule 4 (registered intellectual property) of the charge.. 2. trademarks.. Family: 4; mark: thetanix; classes: 1, 5; territory: united kingdom; priority date: 12 november 2013; filing date: 12 november 2013; application no.: 3101576; registration no.: UK00003101576; status: registered.. For further details of the trademarks subject to this charge please see part 1 of schedule 4 (registered intellectual property) of the charge.
Contains fixed charge.
Contains floating charge.
Floating charge covers all the property or undertaking of the company.
Contains negative pledge.

Additional transactions filed against this charge

Additional transactions filed against this charge (PDF links open in a new window)
Type(of transaction) Delivered(to Companies House on this date) View / Download(PDF file, link opens in new window)
Part of the property or undertaking has been released and no longer forms part of the charge (MR05) 9 May 2023 View PDF for Part of the property or undertaking has been released and no longer forms part of the charge (MR05) (2 pages)